A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2018
At a glance
- Drugs ONO 4474 (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms MOTION
- Sponsors Ono Pharmaceutical
- 09 Mar 2018 This trial has been completed in Hungary (End Date:2018-01-09).
- 26 Feb 2018 Status changed from recruiting to discontinued due to buisness reasons .No safety issues were reported.
- 30 Jan 2018 This trial has been completed in Spain (End Date:2018-01-09).